TY - GEN
T1 - Arsenic and cardiovascular disease
T2 - 6th International Congress on Arsenic in the Environment, AS 2016
AU - Navas-Acien, A.
N1 - Publisher Copyright:
© 2016 Taylor & Francis Group, London.
PY - 2016
Y1 - 2016
N2 - Evidence indicates that arsenic may be a risk factor for cardiovascular disease. The car-diovascular effects of arsenic were first mentioned in reports of cases occurring in Argentina and Taiwan around 1917–1920. Ecological studies in Northern Chile advanced our understanding of the impact of adding and removing arsenic in drinking water for the rise and fall of an epidemic of cardiovascular disease in the population, and the importance of early life exposure. Prospective cohort studies from Taiwan and Bangladesh showed a dose-response relationship of chronic moderate-high arsenic exposure in drinking water with the development of coronary heart disease and maybe stroke. At low-moderate arsenic exposure levels, prospective cohort studies in the US have shown an association with coronary heart disease at levels above 10 μg/L. Evidence is needed to assess cardiovascular risk at levels below 10 μg/L, the shape of the dose-response, and the role of arsenic sources of exposure beyond groundwater.
AB - Evidence indicates that arsenic may be a risk factor for cardiovascular disease. The car-diovascular effects of arsenic were first mentioned in reports of cases occurring in Argentina and Taiwan around 1917–1920. Ecological studies in Northern Chile advanced our understanding of the impact of adding and removing arsenic in drinking water for the rise and fall of an epidemic of cardiovascular disease in the population, and the importance of early life exposure. Prospective cohort studies from Taiwan and Bangladesh showed a dose-response relationship of chronic moderate-high arsenic exposure in drinking water with the development of coronary heart disease and maybe stroke. At low-moderate arsenic exposure levels, prospective cohort studies in the US have shown an association with coronary heart disease at levels above 10 μg/L. Evidence is needed to assess cardiovascular risk at levels below 10 μg/L, the shape of the dose-response, and the role of arsenic sources of exposure beyond groundwater.
UR - http://www.scopus.com/inward/record.url?scp=85017016328&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85017016328&partnerID=8YFLogxK
U2 - 10.1201/b20466-8
DO - 10.1201/b20466-8
M3 - Conference contribution
AN - SCOPUS:85017016328
SN - 9781138029415
T3 - Arsenic Research and Global Sustainability - Proceedings of the 6th International Congress on Arsenic in the Environment, AS 2016
SP - 15
EP - 17
BT - Arsenic Research and Global Sustainability - Proceedings of the 6th International Congress on Arsenic in the Environment, AS 2016
A2 - Bhattacharya, Prosun
A2 - Jacks, Gunnar
A2 - Bundschuh, Jochen
A2 - Bhattacharya, Prosun
A2 - Vahter, Marie
A2 - Jarsjo, Jerker
A2 - Jarsjo, Jerker
A2 - Kumpiene, Jurate
A2 - Ahmad, Arslan
A2 - Sparrenbom, Charlotte
A2 - Donselaar, Marinus Eric
A2 - Bundschuh, Jochen
A2 - Naidu, Ravi
A2 - Naidu, Ravi
PB - CRC Press/Balkema
Y2 - 19 June 2016 through 23 June 2016
ER -